# Notable Labs Ltd. (NTBL)

Source: https://www.quantisnow.com/company/NTBL
Generated: 2026-11-18T12:32:06.756Z

- Ticker: NTBL
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2014

## Latest NTBL news and filings

- 2024-10-16 20:30 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-notice-of-delisting-5727554)
- 2024-10-15 10:13 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Bankruptcy or Receivership, Leadership Update](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-bankruptcy-or-receivership-5724411)
- 2024-09-26 15:07 UTC [SEC Form 3] [New insider Zagger Kaile A. claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-zagger-kaile-a-claimed-no-ownership-of-stock-5705671)
- 2024-09-20 11:46 UTC [Analyst Downgrade] [Notable Labs downgraded by JMP Securities](https://www.quantisnow.com/insight/notable-labs-downgraded-by-jmp-securities-5700359)
- 2024-09-19 20:05 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-costs-associated-with-5699611)
- 2024-09-16 20:05 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-leadership-update-5694953)
- 2024-08-29 20:06 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-notable-labs-ltd-5676501)
- 2024-08-29 11:30 UTC [Notable Labs to Present Data on September 4th at SOHO 2024](https://www.quantisnow.com/insight/notable-labs-to-present-data-on-september-4th-at-soho-5675806)
- 2024-08-26 20:49 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-notable-labs-ltd-5672123)
- 2024-08-26 20:34 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-leadership-update-regulation-5672061)
- 2024-08-26 20:05 UTC [Leadership Update] [Notable Labs Announces CEO Transition](https://www.quantisnow.com/insight/notable-labs-announces-ceo-transition-5671793)
- 2024-08-14 20:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-notable-labs-ltd-5659573)
- 2024-08-09 20:01 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-notable-labs-ltd-5652672)
- 2024-08-06 21:20 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-regulation-fd-disclosure-5645685)
- 2024-07-24 11:52 UTC [Market Chatter] [Notable Labs shares are trading lower. The company announced progress for its Phase 2 volasertib program.](https://www.quantisnow.com/insight/notable-labs-shares-are-trading-lower-the-company-announced-progress-5623999)
- 2024-07-24 11:40 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-other-events-financial-5623961)
- 2024-07-24 11:33 UTC [Market Chatter] [Notable Labs Announced Progress For The Phase 2 Volasertib Program Following Receipt Of "clearance To Proceed" From The FDA And Agreement On The Dosing Plan For Its Phase 2 Clinical Trial](https://www.quantisnow.com/insight/notable-labs-announced-progress-for-the-phase-2-volasertib-program-5623943)
- 2024-07-24 11:30 UTC [Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study](https://www.quantisnow.com/insight/notable-labs-receives-fda-clearance-to-proceed-further-with-volasertib-5623916)
- 2024-07-19 20:05 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-notice-of-delisting-5617842)
- 2024-07-01 21:19 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-notable-labs-ltd-5587437)
- 2024-06-20 21:01 UTC [SEC Form S-1] [SEC Form S-1 filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/sec-form-s-1-filed-by-notable-labs-ltd-5569231)
- 2024-05-30 21:04 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-regulation-fd-disclosure-5527076)
- 2024-05-16 16:08 UTC [Market Chatter] [Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $5](https://www.quantisnow.com/insight/chardan-capital-maintains-buy-on-notable-labs-lowers-price-target-5496455)
- 2024-05-15 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-notable-labs-ltd-5493265)
- 2024-05-10 21:18 UTC [SEC Form 4] [Patsi Tuomo was granted 65,247 units of Ordinary Shares (SEC Form 4)](https://www.quantisnow.com/insight/patsi-tuomo-was-granted-65247-units-of-ordinary-shares-sec-5482667)
- 2024-05-10 21:17 UTC [SEC Form 4] [SEC Form 4 filed by Wagner Joseph P](https://www.quantisnow.com/insight/sec-form-4-filed-by-wagner-joseph-p-5482652)
- 2024-05-10 21:12 UTC [SEC Form 4] [Galen Michele was granted 40,247 units of Ordinary Shares (SEC Form 4)](https://www.quantisnow.com/insight/galen-michele-was-granted-40247-units-of-ordinary-shares-sec-5482626)
- 2024-05-10 21:09 UTC [SEC Form 4] [Dubin Thomas I H was granted 40,247 units of Ordinary Shares (SEC Form 4)](https://www.quantisnow.com/insight/dubin-thomas-i-h-was-granted-40247-units-of-ordinary-5482607)
- 2024-05-10 21:07 UTC [SEC Form 4] [Graney Thomas was granted 40,247 units of Ordinary Shares (SEC Form 4)](https://www.quantisnow.com/insight/graney-thomas-was-granted-40247-units-of-ordinary-shares-sec-5482602)
- 2024-05-10 21:06 UTC [SEC Form 4] [Feinberg Peter was granted 40,247 units of Ordinary Shares (SEC Form 4)](https://www.quantisnow.com/insight/feinberg-peter-was-granted-40247-units-of-ordinary-shares-sec-5482595)
- 2024-05-10 21:04 UTC [SEC Form 4] [Bock Thomas was granted 400,000 units of Ordinary Shares (SEC Form 4)](https://www.quantisnow.com/insight/bock-thomas-was-granted-400000-units-of-ordinary-shares-sec-5482576)
- 2024-05-09 20:05 UTC [Conference Announcement] [Notable Labs to Participate in Fireside Chat at the Citizens JMP Securities Life Sciences Conference 2024](https://www.quantisnow.com/insight/notable-labs-to-participate-in-fireside-chat-at-the-citizens-5477255)
- 2024-05-06 20:30 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-regulation-fd-disclosure-5462998)
- 2024-04-19 20:56 UTC [SEC Form S-8] [SEC Form S-8 filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-notable-labs-ltd-5421617)
- 2024-04-15 16:12 UTC [Market Chatter] [JMP Securities Reiterates Market Outperform on Notable Labs, Maintains $9 Price Target](https://www.quantisnow.com/insight/jmp-securities-reiterates-market-outperform-on-notable-labs-maintains-9-5410255)
- 2024-04-15 12:39 UTC [Market Insight] [Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday](https://www.quantisnow.com/insight/cisco-to-rally-around-24-here-are-10-top-analyst-5409743)
- 2024-04-15 11:43 UTC [Market Chatter] [Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $7](https://www.quantisnow.com/insight/chardan-capital-maintains-buy-on-notable-labs-lowers-price-target-5409446)
- 2024-04-12 12:44 UTC [SEC Form 8-K] [Notable Labs Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/notable-labs-ltd-filed-sec-form-8-k-results-of-operations-5407314)
- 2024-04-12 12:00 UTC [Notable Labs Reports 2023 Financial Results and Provides a Business Update](https://www.quantisnow.com/insight/notable-labs-reports-2023-financial-results-and-provides-a-business-5407138)
- 2024-04-11 21:00 UTC [SEC Form 10-K] [SEC Form 10-K filed by Notable Labs Ltd.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-notable-labs-ltd-5406494)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NTBL
- Earnings history: https://www.quantisnow.com/earnings/NTBL
- Dividend history: https://www.quantisnow.com/dividends/NTBL
- Insider transactions: https://www.quantisnow.com/insiders/NTBL
- Options chain: https://www.quantisnow.com/options/NTBL
- SEC 8-K filings only: https://www.quantisnow.com/company/NTBL/8-k
- RSS and alerts for NTBL: https://www.quantisnow.com/docs/rss-feeds.md
